Related Experiment Videos
[Production of HBV surface antigen-specific target cell]
1Institute for Viral Hepatitis, Chongqing University of Medical Sciences, Chongqing 400010.
Summary
Researchers developed a stable HBsAg-expressing cell line for studying hepatitis B virus (HBV) surface antigen-specific cytotoxic T-cell (CTL) responses. This tool aids in understanding HBV immunopathogenesis.
Area of Science:
- Virology
- Immunology
- Cell Biology
Context:
- Hepatitis B virus (HBV) infection remains a significant global health concern.
- Understanding the cytotoxic T-cell (CTL) response is crucial for developing effective HBV therapies.
- Current methods for analyzing HBV-specific CTLs require optimized target cells.
Purpose:
- To construct and characterize a stable cell line expressing hepatitis B virus surface antigen (HBsAg).
- To evaluate the utility of this cell line as a target in HBsAg-specific CTL assays.
- To investigate factors influencing the CTL response during hepatitis development.
Summary:
- A recombinant retrovirus plasmid (PLXSN-S) was used to create a stable HBsAg-expressing cell line (EL4).
- The cell line demonstrated consistent HBsAg expression over 100 passages and proved effective as a target in CTL assays.
- Mice immunized with PLXSN-S and a recombinant adenovirus vector (rAdv-B7-2-S) were used to validate the target cells.
Impact:
- The developed HBsAg-specific target cell line provides a valuable tool for studying HBV-specific CTL responses.
- This resource can advance research into the immunopathogenesis of hepatitis B.
- Facilitates the screening of potential immunotherapies targeting HBV.